1. Home
  2. HITI vs DTIL Comparison

HITI vs DTIL Comparison

Compare HITI & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo High Tide Inc.

HITI

High Tide Inc.

HOLD

Current Price

$2.47

Market Cap

213.6M

Sector

N/A

ML Signal

HOLD

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

HOLD

Current Price

$7.01

Market Cap

194.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HITI
DTIL
Founded
2009
2006
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
213.6M
194.3M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
HITI
DTIL
Price
$2.47
$7.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$6.13
$45.00
AVG Volume (30 Days)
425.3K
232.9K
Earning Date
03-17-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,070,000,000.00
Revenue This Year
$23.73
N/A
Revenue Next Year
$12.80
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.10
$3.53
52 Week High
$4.06
$8.82

Technical Indicators

Market Signals
Indicator
HITI
DTIL
Relative Strength Index (RSI) 54.39 55.65
Support Level $2.43 $4.56
Resistance Level $2.69 $7.84
Average True Range (ATR) 0.11 0.53
MACD 0.02 -0.02
Stochastic Oscillator 51.22 59.50

Price Performance

Historical Comparison
HITI
DTIL

About HITI High Tide Inc.

High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, and others. The company's reportable operating segments are: Bricks and mortar, which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada, followed by the United States of America, and other international markets.

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

Share on Social Networks: